Topical Steroids to Prevent Recurrent Urinary Tract Infections in Uncircumcised Male Infants: a Pilot Study
Part of paid clinical trials in Houston, Texas.
- Sponsor
- Baylor College of Medicine
- Study ID
- NCT07508124
- Phase
- PHASE4
- Status
- Recruiting
Conditions
- Urinary Tract Infection
Eligibility Criteria
- Sex
- MALE
- Age
- 0 Months - 5 Months
- Healthy Volunteers
- Not accepted
Interventions
- betamethasone valerate 0.1% cream — DRUGSteroid cream applied to the foreskin and glans twice a day for four weeks.
- Placebo cream — DRUGPlacebo cream is applied to the foreskin and glans twice a day for four weeks.
Study Details
The goal of this smaller clinical trial is to evaluate the study design of this research to help prepare for a larger research study in the future. The future larger study would focus on whether steroid cream can reduce recurrent urinary tract infections in male infants, who are not circumcised. Male infants, who are enrolled in this study, would receive either the steroid cream or a placebo cream (a look alike cream without steroids). The cream would be applied twice a week for four weeks. Then there would be two follow up visits with the research team to measure whether the infant experienced any urinary tract infections and to measure parent perceptions of their experience participating in the study.
Key Dates
- Start date
- Apr 30, 2026
- Status verified
- Mar 2026
- Primary completion
- Dec 31, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Participants randomized to receive steroid cream
- Placebo Comparator: Participants randomized to receive placebo cream.
Primary Outcome Measure
Feasibility of recruitment across different settings [ Time Frame: up to 2 weeks ]
Central Contacts
- Sowdhamini Wallace, DO, MS18328245447
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Texas Children's Hospital Main campus | Houston | Texas | 77030 | Sowdhamini Wallace, DO, MS (PRINCIPAL_INVESTIGATOR) Grace Truong, MD (SUB_INVESTIGATOR) Chester Koh, MD, MBA (SUB_INVESTIGATOR) Jaqueline Broda, MPAS, PA-C (SUB_INVESTIGATOR) Saamia Masoom, MD (SUB_INVESTIGATOR) |
| Texas Children's Hospital West Campus | Katy | Texas | 77094 | Sowdhamini Wallace, DO, MS (PRINCIPAL_INVESTIGATOR) Marina Bishai, DO (SUB_INVESTIGATOR) |
| Seattle Children's Hospital | Seattle | Washington | 98105 | Eric Coon, MD, MS Eric Coon, MD, MS (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Houston, TX
Related Studies
- Reducing Overuse of Antibiotics at Discharge HomeEnrolling By Invitation · University of Utah · Salt Lake City, Utah
- Chlorhexidine Antiseptic Irrigation of the Bowel Segment During Radical Cystectomy and Urinary DiversionRecruiting · Icahn School of Medicine at Mount Sinai · New York, New York
- The Impact of Irrisept in Reducing Urinary Tract Infection During Urethral Catheter Removal.Recruiting · Ohio State University · Columbus, Ohio
- De-implementing PreOp Urine TestingNot Yet Recruiting · VA Office of Research and Development · Madison, Wisconsin